[1]
Fowden AL, Camm EJ, Sferruzzi-Perri AN. Effects of maternal obesity on placental phenotype. Curr Vasc Pharmacol 2021; 19(2): 113-31.
[http://dx.doi.org/10.2174/1570161118666200513115316]
[http://dx.doi.org/10.2174/1570161118666200513115316]
[2]
Mate A, Reyes-Goya C, Santana-Garrido Á, Vázquez CM. Lifestyle, maternal nutrition and healthy pregnancy. Curr Vasc Pharmacol 2021; 19(2): 132-40.
[http://dx.doi.org/10.2174/1570161118666200401112955]
[http://dx.doi.org/10.2174/1570161118666200401112955]
[3]
Szlapinski SK, Hill DJ. Metabolic adaptations to pregnancy in healthy and gestational diabetic pregnancies: the pancreas -placenta axis. Curr Vasc Pharmacol 2021; 19(2): 141-53.
[http://dx.doi.org/10.2174/1570161118666200320111209]
[http://dx.doi.org/10.2174/1570161118666200320111209]
[4]
Poblete JA, Olmos P. Obesity and gestational diabetes in pregnant care and clinical practice. Curr Vasc Pharmacol 2021; 19(2): 154-64.
[http://dx.doi.org/10.2174/1570161118666200628142353]
[http://dx.doi.org/10.2174/1570161118666200628142353]
[5]
Murthi P, Rajaraman G. Inflammasomes in the pathophysiology of maternal obesity: potential therapeutic targets to reduce long-term adverse health outcomes in the mother and offspring. Curr Vasc Pharmacol 2021; 19(2): 165-55.
[http://dx.doi.org/10.2174/1570161118666200603131536]
[http://dx.doi.org/10.2174/1570161118666200603131536]
[6]
Bedell S, Hutson J, de Vrijer B, Eastabrook G. Effects of maternal obesity and gestational diabetes mellitus on the placenta: current knowledge and targets for therapeutic interventions. Curr Vasc Pharmacol 2021; 19(2): 176-92.
[http://dx.doi.org/10.2174/1570161118666200616144512]
[http://dx.doi.org/10.2174/1570161118666200616144512]
[7]
Carvajal JA, Oporto JI. The myometrium in pregnant women with obesity. Curr Vasc Pharmacol 2021; 19(2): 193-200.
[http://dx.doi.org/10.2174/1570161118666200525133530]
[http://dx.doi.org/10.2174/1570161118666200525133530]
[8]
Lorenzon AR, Moreli JB, de Macedo Melo R, et al. Stromal cell-derived factor (SDF) 2 and the endoplasmic reticulum stress response of trophoblast cells in gestational diabetes mellitus and in vitro hyperglycaemic condition. Curr Vasc Pharmacol 2021; 19(2): 201-9.
[http://dx.doi.org/10.2174/1570161118666200606222123]
[http://dx.doi.org/10.2174/1570161118666200606222123]